CME Articles

Renal & Urology News includes a CME article in every print issue, which will also be available online.

Once you have read the CME article, click on the link at the beginning of each article to take the post-test.

To view the full RUN myCME page, click here.

ADPKD Past, Present, and Future: An Update on the Last Decade of ProgressExternal web site

By Arlene B. Chapman, MD, and Jared J. Grantham, MD, FACP

Latest CME

Shared Decision Making in Managing Idiopathic and Neurogenic OAB

By Michael B. Chancellor, MD, David A. Ginsberg, MD, and Victor W. Nitti, MD |
Communicating effectively about appropriate options and eliciting patient input for overactive bladder can improve outcomes.

FSGS: Talking Points for the Practicing Nephrologist

By Fernando C. Fervenza, MD, PhD, Richard J. Glassock, MD, and Sanjeev Sethi, MD, PhD |
Distinguishing primary from secondary FSGS is crucial because the treatment approaches and therapeutic goals differ.

Kidney Function Assessment: The Need for a Confirmatory Test

By Leslie A. Inker, MD, MS |
Confirmation of creatinine-based eGFR should be performed in select circumstances using, where appropriate, either measured GFR or cystatin C.

PCA3: What Is Its Role in Prostate Cancer Screening?

By Reza Mehrazin, MD, and Marc C. Smaldone, MD, MSHP |
PCA3 has garnered substantial attention following FDA approval and its role in the diagnosis of PCa will grow.

New Ablative Techniques in Urologic Oncology

By Jeffrey J. Tomaszewski, MD, and David Y.T. Chen, MD |
Innovative approaches offer the potential for effective treatments to limited target 
areas with improved side effect profiles.

Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk

By Daniel J. Canter, MD |
Elderly patients face greater perioperative risks and postoperative mortality.

Dietary Interventions for Treating Progressive Chronic Kidney Disease

By Csaba P. Kovesdy, MD |
The type and amount of ingested protein affects clinical outcomes such as protein-energy wasting, kidney function and even survival.

OAB: Current and Emerging Therapies for Optimal Individualized Treatment

By Michael B. Chancellor, MD, and David A. Ginsberg, MD |
Keeping abreast of the most current treatments for idiopathic OAB can lead to improved outcomes and quality of life.

Update on the Medical Management of Kidney Stones

By David S. Goldfarb, MD, and Lama Nazzal, MD |
The first step in prevention is adequate and quantitative counseling regarding fluid intake, which is effective and inexpensive.

Managing Bone Loss Associated with Androgen Deprivation Therapy

By J. Bryant Byrd, MD, and William J. Aronson, MD |
While bone loss and reduction in bone mineral density are well known consequences of ADT, the main concern is increased risk of osteoporotic fractures.

More CME Articles

Medical and Surgical Management of Bladder Outlet Obstruction

Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.

Adrenal Masses: Often Incidental, Not Always Insignificant

Given the frequency with which these lesions are found, urologists and nephrologists should be familiar with their evaluation.

Thyroid Functional Disease in Dialysis Patients

Emerging data suggest that thyroid hormone deficiency may be associated with 
greater cardiovascular morbidity and mortality in this population.

Pre-treatment Percutaneous Biopsy of Small Renal Masses

Urologists typically treat a renal cortical mass without biopsy, but this should be re-evaluated in the era of the incidental small renal cortical neoplasm.

The Association Between Kidney Failure and Renal Cell Carcinoma

Scientific speculation suggests that uremic toxins, viral mediators, and immune ­inhibition could play a role in malignant transformation.

Current Controversies Surrounding PSA Screening

It is hoped that selective screening, selective biopsy, and selective therapy will 
further decrease the morbidity associated with screening.

Nonmuscle Invasive Bladder Cancer: Guidelines for Treatment

The routine incorporation of NMIBC clinical practice guidelines will reduce variation in care by closing the gap on inappropriate delivery, whether over- or underuse.

The Evaluation and Treatment of Resistant Hypertension

With increased incidence of obesity—and higher caloric and salt intake—in the general population, resistant hypertension is more prevalent than ever.

Adrenal Hypertension: A Current Guide to Diagnosis

Given the intimate anatomical and physiological relationship of the adrenals to the kidney, an understanding of adrenal disease is imperative for urologists and nephrologists alike.

An Update: Radiation or Surgery for Prostate Cancer

The management of patients with high-risk prostate cancer represents one of the ­biggest challenges today, with little consensus on optimal treatment.

Part II: Current Treatment Options for Neurogenic Bladder Dysfunction

Clinicians need to keep abreast of the most current treatment options for NGB, which can result in improved patient outcomes and quality of life.

An Update on the Management of Lupus Nephritis

Approximately 30%-50% of SLE patients have clinically evident renal disease at ­presentation, but renal involvement occurs in up to 60% of patients overall.

Part III: Clinical Challenges and Renal Considerations in Managing Gout

A case study involving a 58-year-old man with acute gout attacks and multiple ­comorbidities, including hypertension and hypercholesterolemia.

Managing Bone Disease in Kidney Transplant Recipients

Pre-existing renal osteodystrophy at the time of transplantation, reduced renal 
function, and transplantation-specific therapies are the main contributing factors.

Part I: Assessment and Diagnostic Strategies for Neurogenic Bladder

Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients

Part II: Clinical Challenges and Renal Considerations in Managing Gout

A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.

Clinical Challenges and Renal Considerations In Managing Gout

A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.

The Management of Patients After Renal Transplantation

Patients who undergo renal transplantation require complex care that involves a diligent, multidisciplinary approach.

An Update on Robotic-Assisted Partial Nephrectomy

Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors.

A Nephrologic Perspective on the Management of Gout

Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well-studied in this patient group.

Examining the Pharmacoeconomics of Advanced Prostate Cancer

In determining prostate cancer treatment, physicians should discuss preferences, values, and expectations with patients, including life expectancy, adverse events, and costs

Hyponatremia: An Update on the Management of SIADH

Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists

Intermittent ADT in Prostate Cancer: A Step-by-Step Approach

In select patients, use of intermittent therapy does not appear to negatively affect overall survival and is associated with fewer adverse events.

Prostatitis and Chronic Pelvic Pain Syndrome: An Update

Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.

Cause-Specific Outcomes Associated with Hypovitaminosis D

The complex biological actions of vitamin D suggest its involvement in various pathologies. (This is the second of a two-part CME article.)

Vitamin D and Clinical Outcomes in Patients With and Without CKD: Part I

Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality.

Relationships of Testosterone and Prostate Cancer: A 2011 Perspective

A history of prostate cancer has generally been a contraindication for testosterone therapy, but the clinical model may be changing.

IgA Nephropathy: An Update on Diagnosis and Management

Following a renal biopsy diagnosis of IgA nephropathy, clinicians need to estimate prognosis and design an appropriate short- and long-term treatment strategy.

Classifying Histologic Subtypes of Renal Cell Carcinoma

Recent advances in understanding genetic changes associated with kidney tumor 
formation have led to new pathologic classifications.

Managing Patients Following a Negative Prostate Biopsy

This article addresses the issues that must be understood to navigate the scenario posed by patients that have had a prior negative biopsy.

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease.

Sign Up for Free e-newsletters